Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $14K 164 sh | Jan 14, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $33K 381 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $4,740 55 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $167K 2,105 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $122K 1,328 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 776 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 775 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 868 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 869 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $84K 986 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | Saba Capital Management, L.P.10% Owner |  GFNEW GERMANY FUND INCOpen-market sale | SELL | $24K 2,000 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $53K 637 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $14K 39 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $34K 96 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Nagendran SukumarDirector, President and Head of R&D |  TSHATaysha Gene Therapies, Inc.Open-market sale · 10b5-1 plan | SELL | $942K 200.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $745 2 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Tuffin PaulaGeneral Counsel and CCO |  BETRBetter Home & Finance Holding CoOpen-market sale · 10b5-1 plan | SELL | $297K 7,698 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $31K 85 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $26K 73 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 40 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Papadopoulos DidierPresident of Aircraft OEM |  JOBYJoby Aviation, Inc.Open-market sale · 10b5-1 plan | SELL | $20K 1,367 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $35K 98 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $17K 47 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $5,242 14 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $7,047 19 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $18K 50 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 42 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $44K 123 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $7,137 19 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $5,667 15 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 19 | Kao John EDirector, Chief Executive Officer |  ALHCAlignment Healthcare, Inc.Open-market sale · 10b5-1 plan | SELL | $59K 2,727 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 19 | Piskel KyleChief Financial Officer | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $77K 4,290 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 19 | Bowles GregoryChief Policy Officer | JOBYJoby Aviation, Inc. Open-market sale · 10b5-1 plan | SELL | $79K 5,383 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $8,791 109 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2,327 27 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 447 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 18 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $8,850 108 sh | Jan 14, 2026 traded Jan 12, 2026 |